Barrow Brain Tumor Research Center, Department of Neurological Surgery, Barrow Neurological Institute, Phoenix, Arizona, USA.
J Neurosurg. 2011 Nov;115(5):948-65. doi: 10.3171/2011.7.JNS101238.
In recent years, advances in the understanding of low-grade glioma (LGG) biology have driven new paradigms in molecular markers, diagnostic imaging, operative techniques and technologies, and adjuvant therapies. Taken together, these developments are collectively pushing the envelope toward improved quality of life and survival. In this article, the authors evaluate the recent literature to synthesize a comprehensive review of LGGs in the modern neurosurgical era.
近年来,对低级别胶质瘤 (LGG) 生物学的认识的进步推动了分子标志物、诊断成像、手术技术和技术以及辅助治疗的新范式。这些进展共同推动了提高生活质量和生存的极限。在本文中,作者评估了最近的文献,综合了现代神经外科学时代 LGG 的综述。